Question

Difficulty: Very hardRheumatology and Immunology

A 42-year-old woman is brought to the emergency department by her husband due to sudden-onset, severe weakness in her legs that rapidly progressed over the last 12 hours. She is now unable to stand or bear weight. She also reports feeling intensely "short of breath." Her medical history is significant for a 5-year history of primary Sjögren syndrome, for which she takes artificial tears and cevimeline. Vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), pulse 105/min, blood pressure 115/75 mm Hg, and respirations 26/min. Oxygen saturation is 98% on room air.

Physical examination reveals a tachypneic woman taking deep, rapid breaths. Lungs are clear to auscultation bilaterally. Neurologic examination shows 1/5 motor strength in the bilateral lower extremities and 3/5 in the upper extremities. Deep tendon reflexes are absent globally. Sensation is intact.

Laboratory results are as follows:

Laboratory ParameterResultReference Range
Serum chemistry
Sodium139 mEq/L136–145 mEq/L
Potassium1.7 mEq/L3.5–5.0 mEq/L
Chloride114 mEq/L98–106 mEq/L
Bicarbonate12 mEq/L22–28 mEq/L
Arterial blood gas (room air)
pH7.257.35–7.45
pCO2pCO_226 mm Hg35–45 mm Hg
pO2pO_298 mm Hg80–100 mm Hg
Urinalysis
pH7.04.5–8.0
Leukocyte esterasePositiveNegative
NitritesPositiveNegative
Thyroid function tests
TSH0.3 μ\muU/mL0.4–4.0 μ\muU/mL
Free T4T_41.1 ng/dL0.9–1.7 ng/dL

Which of the following is the most appropriate next step in the management of this patient?

  1. Intravenous potassium chloride administrationAnswer
  2. B
    Endotracheal intubation and mechanical ventilation
  3. C
    Intravenous piperacillin-tazobactam administration
  4. D
    Oral levothyroxine administration
  5. E
    Intravenous furosemide and continuous positive airway pressure

Answer

Intravenous potassium chloride administration
The correct intervention is intravenous potassium chloride administration. This patient's acute flaccid paralysis is the result of life-threatening hypokalemia (1.71.7 mEq/L). The underlying pathophysiology is Type 1 (distal) renal tubular acidosis (RTA), a known complication of primary Sjögren syndrome caused by autoimmune tubulointerstitial nephritis. Type 1 RTA is characterized by a normal anion gap metabolic acidosis (her AG is 13), severe hypokalemia, and an inability to acidify the urine (urine pH > 5.5; hers is 7.0). The severe hypokalemia alters the resting membrane potential of muscle cells, leading to profound weakness, areflexia, and potentially fatal cardiac arrhythmias or diaphragmatic paralysis. Immediate, aggressive intravenous potassium repletion is the highest priority.

Step-by-Step Solution

1
Analyze the acid-base disorder using the serum chemistry and arterial blood gas.
The patient has a normal anion gap metabolic acidosis (AG = 139 - [114 + 12] = 13). Winter's formula (1.5×12+8=26±21.5 \times 12 + 8 = 26 \pm 2) perfectly matches the measured pCO2pCO_2 of 26 mm Hg, indicating appropriate respiratory compensation.
Characterizing the acid-base status distinguishes between respiratory failure and metabolic derangements.
2
Identify the etiology of the normal anion gap metabolic acidosis.
The combination of severe hypokalemia (1.71.7 mEq/L) and an inappropriately alkaline urine pH (7.07.0) in the setting of a normal anion gap acidosis points to distal (Type 1) Renal Tubular Acidosis (RTA).
Type 1 RTA involves a failure of alpha-intercalated cells to secrete hydrogen ions, leading to hypokalemia, metabolic acidosis, and alkaline urine.
3
Connect the renal pathology to the patient's rheumatologic history.
Primary Sjögren syndrome is a classic cause of Type 1 RTA due to lymphocytic infiltration of the renal interstitium (tubulointerstitial nephritis) damaging the distal tubules.
Recognizing systemic complications of autoimmune diseases is essential for comprehensive rheumatologic care.
4
Determine the most critical immediate intervention.
The patient's acute flaccid paralysis and absent reflexes are directly caused by profound hypokalemia. Immediate intravenous potassium chloride is required.
Severe hypokalemia (<2.0< 2.0 mEq/L) can rapidly lead to fatal cardiac arrhythmias and diaphragmatic failure.

Key Concept

Patients with primary Sjögren syndrome can develop tubulointerstitial nephritis leading to Type 1 (distal) renal tubular acidosis, which can present acutely with life-threatening hypokalemic flaccid paralysis requiring immediate intravenous potassium replacement.
Rate this question